In this educational podcast, experts discuss emerging therapies for their ability to improve outcomes in patients with ocular surface disease. Faculty also review the safety and efficacy data to support new and emerging treatment options for OSD.

This educational podcast will review important considerations for the diagnosis and management of ocular surface disease (OSD) in special patient populations. Faculty will provide pearls for preventing and managing OSD in individuals at elevated risk, including those undergoing ocular surgery, those with glaucoma or diabetes, as well as individuals on medications known to disrupt the ocular surface. 

Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions, Volume, 10, Issue 1

In this podcast, expert clinicians will discuss best practices regarding the use of Port Delivery System with ranibizumab.

In this podcast, expert clinicians will discuss achieving vascular stability through inhibition of Ang-2.

To obtain CME credit, go here: https://tinyurl.com/y58538ef 

In this podcast, expert clinicians will discuss emerging gene therapies for AMD and DME.

To obtain CME credit, go here: https://tinyurl.com/yusxpn44 

In this podcast, expert clinicians will discuss emerging delivery system devices in neovascular retinal disease.

To obtain CME credit, please go here: https://tinyurl.com/thma9fwp

Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and Christina Weng assess the effect of treating RVO early in its course for the improvement of visual outcomes.

Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and Christina Weng discuss the current use of imaging and biomarkers in the diagnosis as well as prognosis of RVO.

Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and David Eichenbaum examine innovations in imaging that can improve the monitoring of treatment response in patients with RVO.